Literature DB >> 19372061

Ankylosing spondylitis and systemic sclerosis: a rare combination.

Dieu-Donné Ouédraogo1, Elisabeth Palazzo, Mireille Nlomé-Nzé, Nathalie Somogyi-Demerjian, Olivier Meyer.   

Abstract

We report a case of diffuse systemic sclerosis (skin, joints, esophagus, and Raynaud's phenomenon) in a 41-year-old Caucasian male with a 15-year history of ankylosing spondylitis and an episode of severe myocarditis of unknown origin. His HLA type included both the B27 allele conferring susceptibility to ankylosing spondylitis and the B35, DRB1 11, and DQB1 03 described as associated with systemic sclerosis. This case-report confirms that two inflammatory joint diseases may co-exist, particularly in patients carrying one or two susceptibility alleles to both diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372061     DOI: 10.1016/j.jbspin.2006.07.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  2 in total

Review 1.  Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review.

Authors:  Avgoustina Kyriakou; Konstantinos Parperis; Elena Nikiphorou; Savvas Psarelis
Journal:  Rheumatol Int       Date:  2021-01-12       Impact factor: 2.631

2.  Patient with ankylosing spondylitis and scleroderma renal crisis.

Authors:  Aliki I Venetsanopoulou; Ourania Argyropoulou; Athanasios G Tzioufas
Journal:  Mediterr J Rheumatol       Date:  2018-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.